CoChat

Testosterone, Sex Hormone-Binding Globulin and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

Open access
Jaruvongvanich, Veeravich, Sanguankeo, Anawin, Riangwiwat, Tanawan, Upala, Sikarin · 2017 · Annals of Hepatology
Cited by 128

The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.

Abstract

Endogenous sex hormones are associated with the risk of diabetes and metabolic syndrome. Recent studies suggested the role of these hormones in nonalcoholic fatty liver disease (NAFLD). We conducted a systematic review and meta-analysis of observational studies investigating the association between sex hormones and NAFLD. A comprehensive search of the databases of the MEDLINE and EMBASE was performed from inception through April 2016. The inclusion criterion was the observational studies that assessed the association of serum total testosterone (TT) and sex-hormone binding globulin (SHBG) and NAFLD. We calculated pooled effect estimates of TT and SHBG with 95% confidence intervals (CI) comparing between subjects with and without NAFLD by using random-effects model. Sixteen trials comprising 13,721 men and 5,840 women met the inclusion criteria. TT levels were lower in men with NAFLD (MD = -2.78 nmol/l, 95%CI -3.40 to -2.15, I2 = 99%) than in those without. Men with higher TT levels had lower odds of NAFLD whereas higher TT levels increased the odds of NAFLD in women. In both sexes, SHBG levels were lower in patients with NAFLD than controls and this inverse association was stronger in women than men and higher SHBG levels were associated with reduced odds of NAFLD. Our meta-anal-ysis demonstrated a sex-dependent association between TT and NAFLD. Lower TT levels are associated with men with NAFLD and inversely associated with women with NAFLD, whereas higher SHBG levels are associated with lower NAFLD odds in both men and women.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5604/01.3001.0009.8593

Cites

17 of 17 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Research works printed but not linked: 43

  1. Rinella, 2015, Nonalcoholic fatty liver disease: a systematic review, JAMA, 313, 2263, 10.1001/jama.2015.5370 · DOI · Paper page
  2. Vernon, 2011, Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults, Alimentary pharmacology & therapeutics, 34, 274, 10.1111/j.1365-2036.2011.04724.x · DOI · Paper page
  3. Jaruvongvanich, 2016, Significant Association Between Gallstone Disease and Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis
  4. Marchesini, 2003, Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome, Hepatology, 37, 917, 10.1053/jhep.2003.50161 · DOI · Paper page
  5. van der Poorten, 2008, Visceral fat: a key mediator of st-eatohepatitis in metabolic liver disease, Hepatology, 48, 449, 10.1002/hep.22350 · DOI · Paper page
  6. Endre, 1996, Low testosterone and insulin resistance in hypertension-prone men, . J Human Hypertension, 10, 755
  7. Kelly, 2015, Testosterone and obesity, Obesity Reviews, 16, 581, 10.1111/obr.12282 · DOI · Paper page
  8. Tok, 2004, The androgenic profile of women with non-insulin-dependent diabetes mellitus, The Journal of reproductive medicine, 49, 746
  9. Toprak, 2001, Insulin resistance in nonobese patients with polycystic ovary syndrome, Hormone Research, 55, 65, 10.1159/000049972 · DOI · Paper page
  10. Kalish, 2003, Postmenopausal Estrogen/Progestin Intervention T. Association of endogenous sex hormones and insulin resistance among postmenopausal women: results from the Postmen-opausal Estrogen/Progestin Intervention Trial, The Journal Of Clinical Endocrinology And Metabolism, 88, 1646, 10.1210/jc.2002-021375 · DOI · Paper page
  11. Pugeat, 2010, Sex hormone-binding globulin gene expression in the liver: drugs and the metabolic syndrome, Molecular and cellular Endocrinology, 316, 53, 10.1016/j.mce.2009.09.020 · DOI
  12. Stroup, 2000, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group, JAMA, 283, 2008, 10.1001/jama.283.15.2008 · DOI · Paper page
  13. Higgins, 2003, Measuring inconsistency in meta-analyses, BMJ, 327, 557, 10.1136/bmj.327.7414.557 · DOI · Paper page
  14. Ayonrinde, 2016, Adverse metabolic phenotype of adolescent girls with non-alcoholic fatty liver disease plus polycystic ovary syndrome compared with other girls and boys, J Gastroenter Hepatol, 31, 980, 10.1111/jgh.13241 · DOI · Paper page
  15. Corbould, 2014, Interrelationships of serum androgens, omental adipose tissue metabolism, and nonalcoholic fatty liver disease in obese premenopausal women, Metabolic syndrome and related disorders, 12, 311, 10.1089/met.2013.0105 · DOI
  16. Flechtner-Mors, 2014, Associations of fatty liver disease and other factors affecting serum SHBG concentrations: a population based study on 1657 subjects, Hormone and metabolic research [Hormon- und Stoffwechselforsc-hung = Hormones et metabolisme], 46, 287
  17. Kauffman, 2010, Endocrine factors associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome: do androgens play a role?, Gynecological Endocrinology, 26, 39, 10.3109/09513590903184084 · DOI · Paper page
  18. Kim, 2012, A low level of serum total testosterone is independently associated with nonalcoholic fatty liver disease, BMC Gastro-enterology, 12, 69, 10.1186/1471-230X-12-69 · DOI
  19. Lazo, 2015, Association Between Endogenous Sex Hormones and Liver Fat in a Multiethnic Study of Atherosclerosis, Clin Gastroenterol Hepatol, 13, 1686, 10.1016/j.cgh.2014.12.033 · DOI · Paper page
  20. Li, 2015, Nonalcoholic fatty liver disease and alteration in semen quality and reproductive hormones, Eur J Gastroenterol Hepatol, 27, 1069, 10.1097/MEG.0000000000000408 · DOI · Paper page
  21. Seo, 2015, Prediction of prevalent but not incident non-alcoholic fatty liver disease by levels of serum testosterone, J Gastroenterol Hepatol, 30, 1211, 10.1111/jgh.12935 · DOI · Paper page
  22. Shin, 2011, Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes, Diab Research Clin Pract, 94, 156, 10.1016/j.diabres.2011.07.029 · DOI
  23. Tian, 2012, Oestradiol is a protective factor for non-alcoholic fatty liver disease in healthy men, Obesity reviews, 13, 381, 10.1111/j.1467-789X.2011.00978.x · DOI · Paper page
  24. Volzke, 2010, Hepatic steatosis is associated with low serum testosterone and high serum DHEAS levels in men, Int J Androl, 33, 45, 10.1111/j.1365-2605.2009.00953.x · DOI · Paper page
  25. Wang, 2016, Combined Association of Vitamin D and Sex Hormone Binding Globulin With Nonalcoholic Fatty Liver Disease in Men and Postmenopausal Women: A Cross-Sectional Study, Medicine, 95, e2621, 10.1097/MD.0000000000002621 · DOI
  26. Hua, 2014, Low serum sex hormone-binding globulin is associated with nonalcoholic fatty liver disease in type 2 diabetic patients, Clin Endocrinol, 80, 877, 10.1111/cen.12360 · DOI · Paper page
  27. Polyzos, 2013, Sex steroids and sex hormone-binding globulin in postmenopausal women with nonalcoholic fatty liver disease, Hormones, 12, 405, 10.1007/BF03401306 · DOI
  28. Vassilatou, 2010, Increased androgen bi-oavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome, Human reproduction, 25, 212, 10.1093/humrep/dep380 · DOI · Paper page
  29. Ding, 2006, Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis, JAMA, 295, 1288, 10.1001/jama.295.11.1288 · DOI · Paper page
  30. van der Poll, 1993, Effects of tumor necrosis factor on the hypothalamic-pituitary-testicular axis in healthy men, Metabolism, 42, 303, 10.1016/0026-0495(93)90078-3 · DOI
  31. Tsigos, 1999, Dose-dependent effects of recombinant human inter-leukin-6 on the pituitary-testicular axis, Journal Of Interferon & Cytokine Research, 19, 1271, 10.1089/107999099312948 · DOI · Paper page
  32. Phillips, 2008, Does insulin resistance, visceral adiposity, or a sex hormone alteration underlie the metabolic syndrome? Studies in women, Metabolism, 57, 838, 10.1016/j.metabol.2008.01.029 · DOI
  33. Liu, 2001, Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation, Am J Epidemiology, 154, 489, 10.1093/aje/154.6.489 · DOI · Paper page
  34. Rando, 2011, Sex differences in nuclear receptor-regulated liver metabolic pathways, Biochimica et biophysica acta, 1812, 964, 10.1016/j.bbadis.2010.12.023 · DOI
  35. Peterson, 2014, Potential for sexual conflict assessed via testosterone-mediated transcriptional changes in liver and muscle of a songbird, J Experimental Biol, 217, 507, 10.1242/jeb.089813 · DOI
  36. Stojsavljevic, 2014, Adipokines and proinflammatory cy-tokines, the key mediators in the pathogenesis of nonalcoholic fatty liver disease, World J Gastroenterol, 20, 18070, 10.3748/wjg.v20.i48.18070 · DOI · Paper page
  37. Huang, 2013, Effect of testosterone administration on liver fat in older men with mobility limitation: results from a randomized controlled trial, The Journals Of Gerontology Series A, Biological Sciences And Medical Sciences, 68, 954, 10.1093/gerona/gls259 · DOI · Paper page
  38. Kosaka, 1996, Hepatocellular carcinoma associated with anabolic steroid therapy: report of a case and review of the Japanese literature, J Gastroenterol, 31, 450, 10.1007/BF02355039 · DOI
  39. Socas, 2005, Hepatocellular adenomas associated with anabolic androgenic steroid abuse in bodybuilders: a report of two cases and a review of the literature, Brit J Sports Med, 39, e27, 10.1136/bjsm.2004.013599 · DOI · Paper page
  40. Solbach, 2015, Testosterone-receptor positive hepatocellular carcinoma in a 29-year old bodybuilder with a history of anabolic androgenic steroid abuse: a case report, BMC Gastroenterology, 15, 60, 10.1186/s12876-015-0288-0 · DOI
  41. Xu, 2013, Testosterone therapy and cardiovascular events among men: a systematic review and meta-analysis of placebo-controlled randomized trials, BMC Medicine, 11, 108, 10.1186/1741-7015-11-108 · DOI · Paper page
  42. Lee, 2014, Radiologic evaluation of nonalcoholic fatty liver disease, World J Gastroenterol, 20, 7392, 10.3748/wjg.v20.i23.7392 · DOI · Paper page
  43. Hernaez, 2011, Diagnostic accuracy and reliability of ultra-sonography for the detection of fatty liver: a meta-analysis, Hepatology, 54, 1082, 10.1002/hep.24452 · DOI · Paper page

Cited by

See all 128

Metadata

Authors
Jaruvongvanich, V., Sanguankeo, A., Riangwiwat, T., & Upala, S.
Venue
Annals of Hepatology
Publisher
Elsevier BV
Published
2017-05
Volume
16
Issue
3
Pages
382-394
ISSN
1665-2681 (ISSN-L)
OpenAlex
W4242526017
Cited by
128
References
17
FWCI
1.64
Type
journal article
Language
en
Open access
hybrid
Licence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.